Carbazole-9-carboxylic Acid

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: Carbazole-9-carboxylic Acid
• 化学式: C₁₃H₉NO₂
• 分子量: 211.22
• InChiKey: XWQRAGBOSRDHGZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  16
• 可旋转键数：
  0
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  42.2
• 氢给体数：
  1
• 氢受体数：
  2

文献信息

• [EN] FUNCTIONALISED AND SUBSTITUTED CARBAZOLES AS ANTI-CANCER AGENTS<br/>[FR] CARBAZOLES FONCTIONNALISÉS ET SUBSTITUÉS UTILISÉS EN TANT QU'AGENTS ANTI-CANCÉREUX
  申请人：NOVOGEN LTD

  公开号：WO2016008010A1

  公开（公告）日：2016-01-21

  The present invention relates to anti-tropomyosin compounds, processes for their preparation, and methods for treating or preventing a disease or disorder, such as a proliferative disease (preferably cancer), using compounds of the invention.

  本发明涉及抗肌球蛋白化合物，其制备方法，以及利用本发明的化合物治疗或预防疾病或紊乱的方法，如增生性疾病（最好是癌症）。
• Novel Imaging Agents for Detecting Neurological Dysfunction
  申请人：Kolb Hartmuth C.

  公开号：US20110046378A1

  公开（公告）日：2011-02-24

  Disclosed here in are compounds and methods of diagnosing Alzheimer's Disease or a predisposition thereto in a mammal, the method comprising administering to the mammal a diagnostically effective amount of a radiolabeled compound, wherein the compound is selected from the group consisting of radiolabeled flavones, coumarins, carbazoles, quinolinones, chromenones, imidazoles and triazoles derivatives, allowing the compound to distribute into the brain tissue, and imaging the brain tissue, wherein an increase in binding of the compound to the brain tissue compared to a normal control level of binding indicates that the mammal is suffering from or is at risk of developing Alzheimer's Disease

  本文披露了一种诊断哺乳动物阿尔茨海默病或其易感性的化合物和方法，该方法包括向哺乳动物施用诊断有效量的放射性标记化合物，所述化合物选自放射性标记的黄酮类、香豆素类、咔唑类、喹啉酮类、香豆素酮类、咪唑类和三唑类衍生物组，使化合物分布到脑组织中，并成像脑组织，其中与正常结合水平相比，化合物与脑组织的结合增加表明该哺乳动物正在患有或有发展阿尔茨海默病的风险。
• INTEGRIN AGONISTS OR ACTIVATING COMPOUNDS AND METHODS FOR MAKING AND USING SAME
  申请人：7 Hills Pharma LLC

  公开号：US20220118086A1

  公开（公告）日：2022-04-21

  Small molecule integrin agonists or integrin activating compounds including at least one di-alkylaryl amine end group and at least one alkyl or alkenoxy linking group including at least one protonatable moiety, wherein the compounds enhance vaccine efficacies, enhance adoptive cell therapy efficacies, enhance immunotherapy efficacies, enhance therapeutic antibody therapy efficacies, enhance checkpoint inhibitor therapy efficacies, enhance effector cell therapy efficacies, and enhanced cell based transplant efficacies and wherein at protonatable moiety either protonate at biological pHs or bears a charge with associated pharmaceutically acceptable counterion making the compound water soluble to improve bioavailability and methods for making and using same.

  小分子整合素激动剂或整合素活化化合物，包括至少一个二烷基芳基胺末端基团和至少一个烷基或烯氧基连接基团，其中包括至少一个可质子化基团，这些化合物增强疫苗效力、增强养护细胞治疗效力、增强免疫疗法效力、增强治疗性抗体疗法效力、增强检查点抑制剂疗法效力、增强效应细胞治疗效力以及增强基于细胞的移植效力。其中，可质子化基团在生物pH下质子化或带有相关的医药可接受的对离子，使化合物水溶性以提高生物利用度，并提供制备和使用的方法。
• METHOD OF PULPING COTTON-BASED RAW MATERIAL
  申请人：LENZING AKTIENGESELLSCHAFT

  公开号：EP3339504A1

  公开（公告）日：2018-06-27

  The present invention relates to a method of pulping cotton-based raw material for producing dissolving pulp. More specifically, the invention relates to a process for producing dissolving pulp under alkaline conditions in combination with a gaseous oxidizing agent. The present invention further relates to dissolving pulp obtainable by pulping cotton-based raw material, in particular dissolving pulp obtainable by the method of the present invention, the use of such dissolving pulp for producing regenerated cellulose molded bodies, and methods of producing lyocell or viscose including such dissolving pulp.

  本发明涉及一种生产溶解浆的棉基原料制浆方法。更具体地说，本发明涉及一种在碱性条件下结合气态氧化剂生产溶解浆的工艺。本发明进一步涉及通过棉基原料打浆获得的溶解浆，特别是通过本发明方法获得的溶解浆，使用这种溶解浆生产再生纤维素模塑体，以及包括这种溶解浆在内的生产纤维素或粘胶的方法。
• DI-SUBSTITUTED 1,4-PIPERIDINE ESTERS AND AMIDES HAVING 5-HT 4? ANTAGONISTIC ACTIVITY
  申请人：BOEHRINGER INGELHEIM ITALIA S.p.A.

  公开号：EP0815080A1

  公开（公告）日：1998-01-07